Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00677235 · ClinicalTrials.gov registry record · NA
Post-Approval Study for the FLAIR Endovascular Stent Graft
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
NCT00677235: Completed NA study, sponsored by C. R. Bard.
NCT00677235 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 270 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00677235, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
Study Summary
The purpose of this study is to confirm the long-term safety and effectiveness of the FLAIR Endovascular Stent Graft for treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous (AV) access grafts.
Primary Outcome
To demonstrate that the post intervention Access Circuit Primary Patency (ACPP) of FLAIR™ is superior to that of PTA at 12 months post study procedure.
Interventions
- DEVICE FLAIR Endovascular Stent Graft
- PROCEDURE PTA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT00677235 record still lists
NCT00677235 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which FLAIR Endovascular Stent Graft is the first listed.
NCT00677235 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00677235 about?
NCT00677235 is a clinical study titled "Post-Approval Study for the FLAIR Endovascular Stent Graft". The purpose of this study is to confirm the long-term safety and effectiveness of the FLAIR Endovascular Stent Graft for treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous (AV) access grafts.
What is the current status of trial NCT00677235?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2008-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00677235?
The interventions under investigation include: FLAIR Endovascular Stent Graft (DEVICE), PTA (PROCEDURE).
Who is sponsoring clinical trial NCT00677235?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00677235's enrollment target sits among peer trials
270 387th of 2000 higher than 1,609 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia